Wells Fargo Maintains Overweight on Teladoc Health, Raises Price Target to $95

Wells Fargo analyst Jamie Stockton maintains Teladoc Health (NYSE:TDOC) with a Overweight and raises the price target from $77 to $95.

Benzinga · 01/08/2020 15:46

Wells Fargo analyst Jamie Stockton maintains Teladoc Health (NYSE:TDOC) with a Overweight and raises the price target from $77 to $95.